• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胸腔积液中 IL-9 产生的 CD4+T 细胞的分化和免疫调节。

Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion.

机构信息

Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, PR China.

出版信息

Am J Respir Crit Care Med. 2012 Dec 1;186(11):1168-79. doi: 10.1164/rccm.201207-1307OC. Epub 2012 Oct 11.

DOI:10.1164/rccm.201207-1307OC
PMID:23065014
Abstract

RATIONALE

IL-9-producing CD4(+) T cells (Th9 cells) have been reported to be involved in inflammation and immune diseases. However, the involvement of Th9 cells in malignancy has not been investigated.

OBJECTIVES

To elucidate the mechanism by which Th9 cells differentiate in malignant pleural effusion (MPE) and to explore the immune regulation of Th9 cells on lung cancer cells.

METHODS

Distribution of Th9 cells in relation to Th17 and Th1 cells in both MPE and blood were determined. The effects and mechanisms of proinflammatory cytokines and regulatory T cells on differentiation of Th9 cells in vitro were explored. The impacts and signal transductions of IL-9, IL-17, and IFN-γ on lung cancer cell lines were also investigated.

MEASUREMENTS AND MAIN RESULTS

The numbers of Th9, Th17, and Th1 cells were all increased in MPE when compared with blood. The increase in Th9 cells in MPE was due to the promotion by cytokines and regulatory T cells. By activating STAT3 signaling, both IL-9 and IL-17 substantially promoted the proliferation and migratory activity of lung cancer cells, whereas IFN-γ, which activated STAT1 signaling, was noted to suppress lung cancer cell proliferation and migration. IFN-γ could induce lung cancer cell apoptosis. Moreover, IL-9 and IFN-γ, but not IL-17, could strongly facilitate intercellular adhesion of lung cancer cells to pleural mesothelial cell monolayers.

CONCLUSIONS

Our data revealed that Th9 cells were increased in MPE and that Th9 cells exerted an important immune regulation on lung cancer cells in human tumor environment.

摘要

背景

已报道产生白细胞介素-9(IL-9)的 CD4(+)T 细胞(Th9 细胞)参与炎症和自身免疫性疾病。然而,Th9 细胞在恶性肿瘤中的作用尚未得到研究。

目的

阐明 Th9 细胞在恶性胸腔积液(MPE)中分化的机制,并探讨 Th9 细胞对肺癌细胞的免疫调节作用。

方法

确定 Th9 细胞在 MPE 和血液中的 Th17 和 Th1 细胞中的分布。体外研究促炎细胞因子和调节性 T 细胞对 Th9 细胞分化的影响和机制。还研究了 IL-9、IL-17 和 IFN-γ 对肺癌细胞系的影响和信号转导。

测量和主要结果

与血液相比,MPE 中 Th9、Th17 和 Th1 细胞的数量均增加。MPE 中 Th9 细胞的增加是由于细胞因子和调节性 T 细胞的促进作用。通过激活 STAT3 信号,IL-9 和 IL-17 均可显著促进肺癌细胞的增殖和迁移活性,而激活 STAT1 信号的 IFN-γ 则可抑制肺癌细胞的增殖和迁移。IFN-γ 可诱导肺癌细胞凋亡。此外,IL-9 和 IFN-γ(而非 IL-17)可强烈促进肺癌细胞与胸膜间皮细胞单层的细胞间黏附。

结论

我们的数据表明 Th9 细胞在 MPE 中增加,并且 Th9 细胞在人类肿瘤环境中对肺癌细胞发挥重要的免疫调节作用。

相似文献

1
Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion.恶性胸腔积液中 IL-9 产生的 CD4+T 细胞的分化和免疫调节。
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1168-79. doi: 10.1164/rccm.201207-1307OC. Epub 2012 Oct 11.
2
Interplay of Th1 and Th17 cells in murine models of malignant pleural effusion.Th1 和 Th17 细胞在恶性胸腔积液小鼠模型中的相互作用。
Am J Respir Crit Care Med. 2014 Mar 15;189(6):697-706. doi: 10.1164/rccm.201310-1776OC.
3
Interleukin 22-producing CD4+ T cells in malignant pleural effusion.产生白细胞介素 22 的 CD4+T 细胞在恶性胸腔积液中的作用。
Cancer Lett. 2012 Dec 29;326(1):23-32. doi: 10.1016/j.canlet.2012.07.013. Epub 2012 Jul 16.
4
Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion.恶性胸腔积液中产生白细胞介素-17 的 CD4+T 细胞的生成和分化。
J Immunol. 2010 Nov 15;185(10):6348-54. doi: 10.4049/jimmunol.1001728. Epub 2010 Oct 15.
5
IL-27 and IL-27-producing CD4+ T cells in human tuberculous pleural effusion.人结核性胸腔积液中的白细胞介素-27及产生白细胞介素-27的CD4 + T细胞
Tuberculosis (Edinb). 2014 Dec;94(6):579-88. doi: 10.1016/j.tube.2014.07.003.
6
Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism.白细胞介素-17 通过白细胞介素-9 依赖的机制抑制恶性胸腔积液的发展。
Sci China Life Sci. 2016 Dec;59(12):1297-1304. doi: 10.1007/s11427-016-0097-y. Epub 2016 Aug 17.
7
[Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].[胸腔内热灌注对恶性胸腔积液肺癌患者细胞因子TH1/TH2免疫反应状态的影响]
Ai Zheng. 2008 Feb;27(2):210-3.
8
T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.与结核性胸腔积液相比,恶性胸腔积液中1型辅助性T细胞/2型辅助性T细胞平衡情况
Chest. 2005 Dec;128(6):4030-5. doi: 10.1378/chest.128.6.4030.
9
Immune Regulation of Toll-Like Receptor 2 Engagement on CD4 T Cells in Murine Models of Malignant Pleural Effusion.恶性胸腔积液小鼠模型中Toll样受体2与CD4 T细胞结合的免疫调节
Am J Respir Cell Mol Biol. 2017 Mar;56(3):342-352. doi: 10.1165/rcmb.2015-0396OC.
10
Recruitment and phenotypic characteristics of interleukin 9-producing CD4+ T cells in malignant pleural effusion.恶性胸腔积液中白细胞介素 9 产生的 CD4+T 细胞的募集和表型特征。
Lung. 2013 Aug;191(4):385-9. doi: 10.1007/s00408-013-9474-4. Epub 2013 May 23.

引用本文的文献

1
Retrospective prognostic evaluation and single-cell transcriptomic analyses of non-small cell lung carcinoma with malignant pleural effusion.伴有恶性胸腔积液的非小细胞肺癌的回顾性预后评估及单细胞转录组分析
Transl Cancer Res. 2025 Jun 30;14(6):3500-3519. doi: 10.21037/tcr-2024-2581. Epub 2025 Jun 25.
2
Development of therapeutic cancer vaccines based on cancer immunity cycle.基于癌症免疫循环的治疗性癌症疫苗的开发。
Front Med. 2025 Jul 14. doi: 10.1007/s11684-025-1134-6.
3
Based on the immune system: the role of the IL-2 family in pancreatic disease.
基于免疫系统:白细胞介素-2家族在胰腺疾病中的作用
Front Immunol. 2025 Jan 31;16:1480496. doi: 10.3389/fimmu.2025.1480496. eCollection 2025.
4
Natural lung-tropic T9 cells: a sharp weapon for established lung metastases.天然肺嗜性T9细胞:已形成肺转移的利器。
J Immunother Cancer. 2024 Dec 4;12(12):e009629. doi: 10.1136/jitc-2024-009629.
5
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?Th17细胞在癌症中的作用:免疫抑制剂还是抗肿瘤盟友?
Cancer Cell Int. 2024 Oct 27;24(1):355. doi: 10.1186/s12935-024-03525-9.
6
Functional diversity and regulation of IL-9-producing T cells in cancer immunotherapy.在癌症免疫治疗中,IL-9 产生 T 细胞的功能多样性和调控。
Cancer Lett. 2024 Dec 1;606:217306. doi: 10.1016/j.canlet.2024.217306. Epub 2024 Oct 18.
7
Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications.恶性胸腔积液中的免疫调节:从微环境到治疗意义
Cancer Cell Int. 2024 Mar 12;24(1):105. doi: 10.1186/s12935-024-03211-w.
8
Characterization of the alternative splicing landscape in lung adenocarcinoma reveals novel prognosis signature associated with B cells.肺腺癌中可变剪接图谱的特征分析揭示了与 B 细胞相关的新型预后特征。
PLoS One. 2023 Jul 11;18(7):e0279018. doi: 10.1371/journal.pone.0279018. eCollection 2023.
9
The World according to IL-9.《白细胞介素-9 世界》
J Immunol. 2023 Jul 1;211(1):7-14. doi: 10.4049/jimmunol.2300094.
10
T cells in health and disease.健康与疾病中的 T 细胞。
Signal Transduct Target Ther. 2023 Jun 19;8(1):235. doi: 10.1038/s41392-023-01471-y.